Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Invested Capital: 2009-2025

Historic Invested Capital for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $10.3 million.

  • China Pharma Holdings' Invested Capital rose 35.67% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year increase of 35.67%. This contributed to the annual value of $8.9 million for FY2024, which is 3.54% up from last year.
  • As of Q3 2025, China Pharma Holdings' Invested Capital stood at $10.3 million, which was up 30.50% from $7.9 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Invested Capital ranged from a high of $11.2 million in Q3 2021 and a low of $4.7 million during Q4 2022.
  • For the 3-year period, China Pharma Holdings' Invested Capital averaged around $8.3 million, with its median value being $8.1 million (2025).
  • Per our database at Business Quant, China Pharma Holdings' Invested Capital slumped by 54.29% in 2022 and then spiked by 81.57% in 2023.
  • Over the past 5 years, China Pharma Holdings' Invested Capital (Quarterly) stood at $10.3 million in 2021, then crashed by 54.29% to $4.7 million in 2022, then skyrocketed by 81.57% to $8.6 million in 2023, then rose by 3.54% to $8.9 million in 2024, then spiked by 35.67% to $10.3 million in 2025.
  • Its Invested Capital stands at $10.3 million for Q3 2025, versus $7.9 million for Q2 2025 and $8.1 million for Q1 2025.